How to Build a Blister vs Bottle Risk Assessment


Published on 03/05/2026

Conducting a Risk Assessment for Blister versus Bottle Packaging

In the pharmaceutical industry, selecting the most appropriate packaging for drug products is crucial to ensure safety, efficacy, and patient adherence. This case study addresses a real-world scenario where a pharmaceutical company faced significant challenges in their packaging decision, specifically weighing the use of blister versus bottle packaging. By reading this article, you will learn about effective detection, containment, investigation, and corrective actions pertinent to such packaging-related challenges.

With a focus on practical evidence and real-world failure modes, this article delves into the steps taken to resolve a packaging dilemma while maintaining compliance with regulatory requirements. By the end, you will be equipped with actionable insights applicable to various packaging scenarios.

Symptoms/Signals on the Floor or in the Lab

The issue emerged when operators began reporting an unusually high rate of complaints regarding the integrity of the medicine’s packaging. Specifically, complaints indicated instances of moisture ingress and compromised unit dose integrity for alpha-alumina blister packages intended for sensitive formulations.

Analysis of loss data revealed that over 15% of the batches produced had to be

either reworked or scrapped due to packaging defects. Additional review indicated that physical inspections of the entire blister package line led to a 20% increase in rejection rates during final quality assurance testing.

This situation necessitated an immediate examination of the packaging processes. Essential symptoms observed included:

  • Inconsistencies in seals and adhesive failures.
  • Visible moisture accumulation within the blister cavities.
  • Increased levels of returns from pharmacy partners due to compromised packaging.
  • Feedback from healthcare professionals regarding patient difficulties in dispensing medications from the blister packs.

Likely Causes

Upon initial review, the likely causes of the observed failures could be categorized into six areas: Materials, Method, Machine, Man, Measurement, and Environment (the 6Ms). This structure aids in a thorough analysis:

Category Potential Causes
Materials Inadequate moisture barrier properties, incorrect desiccant placement, insufficient roll stock quality.
Method Inconsistent operating procedures leading to variations in sealing temperatures and times.
Machine Equipment calibration issues, wear and tear on the sealing machines, improper maintenance.
Man Lack of training among operators, inadequate shift handover protocols.
Measurement Poor monitoring of environmental conditions, lack of humidity and temperature data logging.
Environment High humidity levels in the production area impacting packaging integrity.
Pharma Tip:  When to Use Desiccants in Bottle Packaging for Pharma Products

Immediate Containment Actions

In the first 60 minutes following the identification of the issue, several containment actions were implemented to mitigate risk and prevent production of compromised units:

  1. Stop Production: Immediate halting of the blister packaging line to prevent further defective packaging.
  2. Notify Quality Assurance: Quality personnel were alerted to initiate a critical review of current batches and identify any deviations.
  3. Quarantine Affected Batches: All products in inventory from the relevant production runs were quarantined until further investigation.
  4. Initial Environmental Review: An assessment of environmental controls was conducted, focusing on humidity and temperature levels within the packaging area.
  5. Conduct Team Meeting: Formed a cross-functional team of Quality, Engineering, and Production staff to discuss initial findings and brainstorm containment strategies.

Investigation Workflow

The investigation proceeded with the following structured workflow:

  1. Data Collection: Gathering historical production data, environmental monitoring logs, batch records, and inspection reports for the affected packaging lines.
  2. Interviews: Conducting interviews with operators and personnel involved in the packaging process to gain insights into observed issues and any deviations in standard procedures.
  3. Sample Testing: Testing samples from the quarantined batches for moisture levels and integrity to establish the extent of the issues.
  4. Documentation Review: Reviewing all relevant standard operating procedures (SOPs) to evaluate compliance with specified practices preceding the observed failures.

Each facet of the investigation was aimed at identifying discrepancies or lapses that might have contributed to the integrity failure of the packaging.

Root Cause Tools

To facilitate an accurate root cause analysis, the following tools were employed:

  • 5-Why Analysis: This technique was used to drill down into identified issues. For example, querying why moisture ingress occurred led to further exploration of sealing temperatures, equipment condition, and environmental humidity.
  • Fishbone Diagram: Also known as an Ishikawa diagram, it visually illustrated potential categories of causes leading to the greater problem of faulty packaging.
  • Fault Tree Analysis: This method was implemented to map the failure events and determine the relationship between system failures, highlighting any safety risks associated with packaging.

This combination of tools provided a comprehensive picture of contributing factors and prioritized areas for corrective action.

CAPA Strategy

Corrective and preventive actions (CAPA) were established based on findings from the investigation:

  • Correction: Immediate recalibration of sealing machines and revision of heat sealing SOPs, ensuring optimal temperatures and timings are documented and followed.
  • Corrective Action: Implementation of a training program for all operators focused on best practices in packaging, moisture control, and equipment handling.
  • Preventive Action: Establishing a cross-functional team to regularly review environmental data, implementing continuous monitoring systems for humidity and other critical parameters in the packaging environment.
Pharma Tip:  Blister vs Bottle Packaging for Pediatric Solid Oral Products

Control Strategy & Monitoring

The introduction of a robust control strategy was paramount in preventing recurrence:

Related Reads

  • Statistical Process Control (SPC): Implementation of SPC methodologies allowed real-time monitoring of key parameters during the blister packaging process, thereby identifying any deviations immediately.
  • Regular Sampling: Instituted increased frequency of sampling for humidity checks and blister integrity tests in the production environment.
  • Alarm Systems: Set alarms for critical environmental thresholds, alerting staff to deviations before they could impact production.
  • Verification Protocols: Documented verification processes involving routine checks of finished product integrity, ensuring adherence to specifications before product release.

Validation / Re-qualification / Change Control Impact

Understanding the implications on validation was essential, particularly for the new procedural amendments. The following actions were mandated:

  • Validation of Changes: All adjustments made to equipment settings, materials used, and SOPs were validated through a systematic approach to ensure efficacy and safety of the revised packaging processes.
  • Batch Review: Initiated a review process for all batches produced under modified conditions; a shadow batch was produced as a test before full-scale application.
  • Change Control Procedures: Incorporated an impact assessment for the updated preventative measures, ensuring alignment with company quality systems and regulatory expectations.

Inspection Readiness: What Evidence to Show

Ensuring readiness for regulatory inspections involved thorough documentation and evidence collection:

  • Records: Comprehensive documentation of all maintenance records for equipment, including calibration schedules and any unplanned maintenance.
  • Logs: Detailed environmental monitoring logs, including humidity and temperature records corroborating compliance with acceptable ranges.
  • Batch Documentation: Retaining all batch records, including details regarding production processes, testing, and any deviations logged during manufacturing.
  • Deviations: Maintaining records of all deviations encountered and the corresponding investigations undertaken, demonstrating a commitment to quality and continuous improvement.

FAQs

What are the primary differences between blister and bottle packaging?

Blister packaging tends to provide superior moisture barrier properties and dosage integrity for sensitive medications, while HDPE bottles are often better for bulk products with less stringent moisture requirements. Each choice has implications on patient adherence and protection against environmental factors.

Pharma Tip:  Packaging Decision Tree for Immediate-Release Tablets

How can I ensure that my packaging materials provide adequate moisture protection?

Evaluate material specifications against the product stability data. Consider utilizing desiccant canisters in combination with packaging materials known for their moisture barrier capabilities, such as alu-alu blisters.

What steps should I take if I discover a moisture ingress issue?

Immediately freeze production, notify quality assurance teams, conduct an investigation to identify root causes, and implement timely containment and corrective actions as outlined in this guide.

How often should I validate my packaging processes?

Maintaining a schedule based on risk assessment is crucial. Typically, processes should be validated prior to new product launches and upon any significant changes to packaging operations.

What are the regulatory implications of choosing one packaging type over another?

Regulatory bodies like the FDA and EMA expect that any packaging decision must consider stability data, protection against contamination, and how it impacts patient usage. Documentation of this consideration is essential during inspections.

Is training for operators necessary following a packaging issue?

Yes, operator training ensures that staff are aware of best practices, stresses adherence to SOPs, and provides education on the impact of their role in maintaining product quality.

How can I assess risk regarding packaging alternatives?

Using formal risk assessment tools such as FMEA (Failure Mode Effect Analysis) can help in evaluating potential failures with different packaging options and their impact on product quality.

Why is regular environmental monitoring important in packaging?

Regular monitoring ensures environmental conditions remain within specified limits, thus preserving product integrity. Fluctuations can lead to issues like moisture ingress, requiring corrective actions.

What is the role of statistical process control in packaging?

SPC enables continuous monitoring and control of key packaging parameters, allowing companies to reduce variability and maintain consistent product quality.

How long should package integrity testing continue post-correction?

Package integrity testing should continue for at least three production cycles and should be periodically reviewed based on the historical performance of the packaging and any emerging quality data.

What are some best practices for managing change control in packaging operations?

Implement a proactive change management system that includes thorough documentation, impact assessments, and a robust plan for training operators on new procedures to ensure compliance and quality.